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Summary Records of 2,145 cases of Hodgkin's disease in England and Wales treated by the British National
Lymphoma Investigation during 1970-84 were sought in the national and regional cancer registers. One
thousand eight hundred and eight-six (88%) were recorded in the national register, either as Hodgkin's disease
(86%) or as other or unspecified lymphoma (2%) and 2 (0.1%) were recorded as other cancers. A further 69
(3%) cases were registered by regional cancer registries but had not reached the national register. Adjusting for
the distribution of the study cases by region of incidence, we estimate completeness of registration of cases of
Hodgkin's disease in the national register at 89.7%, and in the regional registers overall at 92.9%. Com-
pleteness did not vary appreciably by age or sex or calendar period. There was however, substantial variation
in completeness between regional registries. Estimates were made for all regions except North Western; the
lowest estimated completenesses were under 90% in Wessex, and the Thames registry regions, and the greatest
were 95% or more in Northern, Trent, East Anglia, Oxford, South Western, West Midlands and Mersey.
Because these results are confined to one malignancy treated by a particular collaborative network of
physicians (although a large and widespread one), and because the patients are restricted to those seen in
hospitals, caution must be exercised in extrapolation of the findings to cancer registration generally, but other
studies and sources of information lead to similar conclusions about completeness of cancer registration
nationally and regionally.
Cancer registration has been conducted in parts of England
and Wales since the 1920s, with notionally complete geo-
graphic coverage of the country since 1962. The data are
collected by regional cancer registries; there were 74 such
registries in 1950, diminishing in number over time, such that
now there are 12. Since 1945 the regional registries have sent
data to the national registry (now at the Office of Population
Censuses and Surveys (OPCS)), where they are collated, and
validation and elimination ofduplicates is undertaken. Multi-
ple sources of data are used to ascertain cancers, with the
particular sources varying to some extent between regions
(Swerdlow, 1986). All receive extracts from all deaths
certificates for residents of their region which mention cancer.
The England and Wales data set of over 5 million cancer
registrations is exceptionally large, but its use to examine
secular and cohort trends in cancer incidence and to provide
incidence data in cohort studies, has been hampered by
uncertainty about the degree of completeness of registration.
A study by Villard-Mackintosh et al. (1988) of cancers in
women reported to the Oxford-FPA contraceptive study,
suggested about 89% eventual completeness of registration at
national level in England for cancers incident 1968-83, but
based on very uneven representation of regional registries
and small numbers from many of them. Data for children
suggest 95% completeness of regional registration overall in
England and Wales 1971-84, with 3% of these registrations
failing to reach the national register (Hawkins & Swerdlow,
in press). These studies were based on comparison between
registry data and independently identified lists of cases. Such
a study has also been published for one regional registry
(Nwene & Smith, 1982), estimating 95% completeness in
North Western region in 1974-77. Other published inform-
ation on completeness has been indirect. Mortality to inci-
dence ratios suggest that in some regions, notably the North
Thames regions and Wessex, registration may have been
substantially less complete than the national average at some
periods over the last 20 years (Swerdlow, 1986). Mortality to
incidence ratios give an unsatisfactory assessment of com-
pleteness, however, because of their dependence on several
other factors: for instance they will be affected by secular
trends in case-fatality, duplication of registrations, and
changes in mortality certification practice.
The British National Lymphoma Investigation (BNLI) is a
group of consultants at over 60 hospitals in the UK who
have collaborated since 1970 in clinical trials of treatment of
lymphomas. Cases are reported directly by the consultants to
BNLI, and this gave an opportunity to assess completeness
of the national cancer registration system against an indepen-
dent source based on far larger numbers of cases at adult
ages than in previous studies.
Materials and methods
We extracted from the files of the BNLI, identifying data on
all patients with Hodgkin's disease incident since 1971 and
included in their study files. These cases were checked against
lists of Hodgkin's disease registrations in the national cancer
registry for the year of incidence recorded by the BNLI, and
also for the adjacent incidence years. Because these searches
were clerical, it was not practical to check the cases also
against other years of registrations and other cancer sites in
the national registry (which contains about 200,000 registra-
tions per year). The cases might have been registered in these
other years and sites, however, either because of error or
because of differences in data sources between the BNLI and
the national cancer registry. To check for this possibility,
details of the BNLI patients who could not be found in the
national cancer registry were sent to the National Health
Service Central Register (NHSCR). The NHSCR is a vir-
tually complete population register of England and Wales, on
which, as far as possible, all cancer registrations in the
national cancer register incident since 1971 have been entered
('flagged'). Therefore an attempt was made to trace the
patient on the NHSCR, and if the patient could be identified
there a check was made of whether a cancer registration was
recorded against the individual's name, and this registration
was examined.
When no match of a BNLI case against the national
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cancer register or NHSCR could be made, identifying details
of the case were returned to BNLI for checking and ampli-
fication, and then sent back to NHSCR and the national
cancer registry for a second attempt at matching. If no
cancer registration could still be found, the case was sought
in the appropriate regional cancer register.
We analysed completeness of registration by sex, age,
calendar period and region of residence. The size of sample
available for assessment from each region reflected the
number of BNLI patients treated in that region, rather than
the size of the region's contribution to total national cancer
incidence. Therefore, to estimate national completeness of
registration, allowing for the acutal size of contributions to
the national total from each region, we weighted each region-
al completeness figure in Table III by the number of Hodg-
kin's disease registrations in that region from 1971-84.
Similarly, to determine the percentage of registrations which
though registered regionally failed to reach the national regis-
try, we weighted these regional failure rates in our study data
by the size of the regional contributions to overall national
registrations. We had no data in the study for one region,
North Western, and we therefore used the estimate of com-
pleteness for this region published by Nwene and Smith
(1982) (fortuitously, this was the only region for which such
substantial data on completeness based on direct comparison
with an independent source of cases have been published).
For weighted estimation of failures in transmission of regis-
trations between regional registeries and the national registry,
we assumed that the North Western region failure rate was





















There were 1,378 cases of Hodgkin's disease in males and 767
in females in the BNLI study files for 1971-84. One thou-
sand eight hundred and eight-six (88%) of these cases could
be traced as a cancer registration, either of Hodgkin's disease
or of other or unspecified lymphoma, on the national cancer
register (Table I). A further 69 (3%) could be traced with
these diagnoses in regional cancer registers but not the
national register. Two (0.1%) were registered with other
cancers, because the diagnosis or coding of the cancer on the
regional and national registry files was incorrect. This left
188 (9%) for whom no registration of the cancer could be
found regionally or nationally. In three of these patients, a
subsequent second primary cancer in the patient had been
registered, but the initial Hodgkin's disease had not. There
was no appreciable variation in completeness of registration
over time, and slightly greater completeness for men than for
women.
Completeness did not vary substantially by age (Table II),
except that, based on small numbers, there was lower com-
pleteness at the oldest age-group in the study (75-84 years)
than at other ages.
Regional variation was more considerable (Table III).
While 95% or more of cases were registered in Northern,
Trend, East Anglia, Oxford, South Western, West Midlands
and Mersey regions, under 90% were registered in North
West Thames, North East Thames, South Thames and
Wessex. No cases were available for assessment from North
Western region.
Weighting the regional completeness estimates from the
study by the number of registrations at each registry
1971-84 (see 'Methods'), gave an estimate of overall com-
pleteness of registration in England and Wales at regional
level of 92.8%*. The weighted percentage of registrations
failing to reach the national registry from regional registries
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*Weighting by overall numbers of cancer registrations in each regis-
try rather than numbers of Hodgkin's disease registrations gave very
similar estimates: 92.9% for overall completeness, and 3.2% for
failures of regional registrations to reach the national registry.328 A.J. SWERDLOW et al.
Table II Completeness of registration of BNLI Hodgkin's disease patients by the national and regional cancer registries by age
Registered as Traced on NHSCR, No trace at
Registered Registered as Hodgkin's disease or but no cancer NHSCR, and no
as Hodgkin's other lymphoma other lymphoma Registered as registration cancer registered
disease by by national by regional but not cancer other nationally nationally or
Age-group national registry registry national registry than lymphoma or regionally regionally Total
(years) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
10-24 518 (88) 6 (1) 30 (5) 0 (0) 38 (6) 19 (3) 591 (100)
25-34 507 (90) 8 (1) 12 (2) 0 (0) 37 (7) 6 (1) 564 (100)
35-44 285 (87) 2 (1) 12 (4) 0 (0) 38 (12) 7 (2) 327 (100)
45-54 223 (86) 10 (4) 8 (3) 0 (0) 18 (7) 4 (2) 259 (100)
55-64 217 (88) 4 (2) 3 (1) 1 (0) 21 (9) 1 (0) 246 (100)
65-74 91 (87) 2 (2) 4 (4) 1 (1) 7 (7) 0 (0) 105 (100)
75-84 12 (80) 1 (7) 0 (0) 0 (0) 2 (13) 0 (0) 15 (100)
Total, 10-84 1853 (86) 33 (2) 69 (3) 2 (0) 151 (7) 37 (2) 2145 (100)
Table III Completeness of registration of BNLI Hodgkin's disease patients by the national and regional cancer registries by region of
residence
Registered as Traced on NHSCR, No trace at
Registered Registered as Hodgkin's disease or but no cancer NHSCR, and no
as Hodgkin's other lymphoma other lymphoma Registered as registration cancer registered
disease by by national by regional but not cancer other nationally nationally or
national registry registry national registry than lymphoma or regionally regionally Total
Regiona No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Northern 44 (90) 3 (6) 1 (2) 0 (0) 0 (0) 1 (2) 49 (100)
Yorkshire 187 (88) 8 (4) 3 (1) 1 (0) 11 (5) 2 (1) 212 (100)
Trent 135 (90) 6 (4) 2 (1) 0 (0) 7 (5) 0 (0) 150 (100)
East Anglia 172 (95) 2 (1) 0 (0) 0 (0) 7 (4) 1 (1) 182 (100)
NW Thames 485 (81) 5 (1) 24 (4) 0 (0) 64 (11) 22 (4) 600 (100)
NE Thames 152 (86) 1 (1) 4 (2) 0 (0) 18 (10) 1 (1) 176 (100)
S. Thames 131 (80) 1 (1) 10 (6) 0 (0) 21 (13) 1 (1) 164 (100)
Oxford 29 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 29 (100)
S. Western 139 (93) 1 (1) 3 (2) 0 (0) 5 (3) 2 (1) 150 (100)
Wales 83 (91) 2 (2) 0 (0) 0 (0) 4 (4) 2 (2) 91 (100)
W. Midlands 130 (92) 1 (1) 7 (5) 0 (0) 2 (1) 2 (1) 142 (100)
Mersey 114 (89) 2 (2) 7 (5) 1 (1) 3 (2) 1 (1) 128 (100)
Wessex 52 (72) 1 (1) 8 (11) 0 (0) 9 (12) 2 (3) 72 (100)
Total 1853 (86) 33 (2) 69 (3) 2 (0) 151 (7) 37 (2) 2145 (100)
'No data available for North Western region.
region, for which we did not have data, had the mean failure
rate of the rest of the country. The overall result was robust
to variation in this assumption, however: halving or doubling
the estimate for North Western region altered the national
total by under 0.4% (to 3.0 and 3.4% respectively).
Discussion
The study is based on a far larger sample of malignancies at
adult ages than any previously, but certain methodological
points need to be noted in interpretation.
It is problematic whether registrations with erroneous diag-
nostic codes should be counted as valid when assessing
completeness of registration. We included non-Hodgkin's
lymphoma and unspecified lymphoma diagnoses as valid in
the present estimates, because the diagnoses in the BNLI are
those verified by the BNLI pathology panel, which may differ
from the exact lymphoma diagnoses available locally to
regional cancer registries. We did not include non-lymphoma
registrations as valid, but since these were 0.1% of the total
their inclusion would have made a negligible difference.
Use of the National Health Service Central Register was
the only way by which we could search for registrations in
the national files recorded with a different site, or with an
incidence year substantially discrepant, from that recorded by
the BNLI. (Checks with the regional registries ascertained
these cases for the regional registers but could not determine
whether the information had then reached the national
register.) Use of the NHSCR may have led to marginal
under-estimation of national (but not regional) completeness,
since recorded ofnationally registered cancers in the NHSCR
is somewhat incomplete (see below). The effect of this should
have been small, however, since few registrations are likely to
have been this discrepant in recording of incidence year
(certainly few were found regionally to be substantially dis-
crepant), and most of these should have been in the NHSCR.
Most of the BNLI cases for whom no cancer registration
could be found were in persons traced on the NHSCR, and
hence they should have been eligible for inclusion in the
registration system. The small number of BNLI cases not
traced at NHSCR might have included malignancies in
foreign visitors, which are not within the scope of the Eng-
land and Wales registration scheme. Judging from the names
of the untraced patients and their length of follow up in
Britain by the BNLI, however, such instances were few if
any. Only four of the unregistered cases were lost to follow
up by emigration.
The study was only of one malignancy, Hodgkin's disease,
which might not be representative of cancers overall. In a
study of completeness of registration of many different
cancers in North Western region, however, Nwene and Smith
(1982) found completeness for Hodgkin's disease close to
that for cancers overall. Nevertheless, because of the restric-
tion to one malignancy caution is needed in extrapolation of
the results to cancer registration generally.
Caution is also needed in interpretation because, like
several previous studies comparing cancer registries with an
independent source, the independently identified cases are a
selected sample of all cases in the country, although not one
obviously biased with respect to cancer registration at a
national level. The BNLI includes several major centres and
many smaller ones treating lymphomas in Britain, with a
wide geographic spread. Usually, all of the consultants at a
participating centre are members, but this is not invariably
the case. Many centres have been members throughout theCOMPLETENESS OF CANCER REGISTRATION 329
study period, but some have left or entered during it. The
patients included in the completeness analyses are those in
the BNLI's 'study files', whom the BNLI members have
entered into controlled trials or other clinical studies, and for
whom as a result the BNLI central office hold complete and
detailed information. These patients are the majority of all
patients treated by the BNLI members, but omitting young
children and probably including only a minority of the most
elderly patients. On a national scale there is no obvious
reason why the centres included in the BNLI should be better
or worse in relation to cancer registration than other centres
in the country - cancer registration in England and Wales is
not carried out by the consultants personally, but by clerical
officers, inspection of national death certificates, use of com-
puterised hospital record systems, etc (see Swerdlow, 1986).
At a regional level there is a greater risk that the particular
centres within the BNLI might by chance be atypical ones
with regard to registration, and this seems particularly a
potential problem in the Thames regions where certain major
treatment centres are members of the BNLI and others are
not. This may explain why the findings on completeness by
region, although mainly in line with those one would expect
from other sources (see Swerdlow, 1986), appear better than
might be expected for the North Thames regions. With
regard to analyses of completeness of registration over time,
the fact that some centres have entered BNLI and others left
during the study period means that the results for the early
and late parts of the study period are not based on exactly
the same centres, although the centres entering and leaving
are not obviously ones which would introduce a bias for or
against better registration. Our expectation from other
sources would have been of a small improvement in registra-
tion completeness nationally over the study period, and it is
possible that the lack of such an effect in the data may reflect
small changes in the membership of the BNLI during the
period.
The study was solely of cases diagnosed or treated at
hospitals. Registration completeness for such cases might
differ from that for cases never seen in hospital. The effect of
this should be negligible for Hodgkin's disease, for which
extremely few cases in the country would fail to receive any
hospital diagnosis or treatment. The effect should also be
reasonally small for most other cancers, with the exception of
non-melanoma skin cancer and cancers in the very elderly.
The study included some but not all of the private patients
(who might be worse registered) treated by BNLI consultants
during the period. Again, however, the effect on the study
results should be small, since private patients are a very small
proportion of all Hodgkin's disease patients. The effect of
private patients may be a little larger for certain other malig-
nancies.
The BNLI has continued to enroll patients since 1984, but
we did not include these in the present study because it takes
several years for the national registry to reach its eventual
level of completeness. Few further registrations for years
before 1985 can now be expected to be entered in the region-
al and national registration schemes (Hawkins & Swerdlow,
in press), but to the extent that they do occur the present
completeness estimates may be marginally too low. Eventual
completeness needs as far as possible to be separated analy-
tically from delays in registration, since the extent of the
temporary incompleteness from the latter depends entirely on
the date at which it is assessed. Studies which do not separate
these two elements are difficult to interpret. It should also be
noted that the present data relate only to completeness of
regional and national cancer registers, not to the notification
of cancers to research workers by the National Health Ser-
vice Central Register (NHSCR). Several studies indicate that
this notification is appreciably less complete than the cancer
registers (Hunt & Coleman, 1987; Villard-Mackintosh et al.,
1988; Darby et al., 1988; Hawkins & Swerdlow, in press),
because not all registered cancers reach the NHSCR, and not
all cancers recorded at NHSCR are correctly notified.
Despite the reservations discussed above, the present
results fit with most other available evidence on cancer regist-
ration completeness (after allowance for lag periods). A study
of cancers incident in women of childbearing age and re-
ported to the Oxford-FPA contraceptive study included 267
cases, incident 1968- 83, for whom at least 41 years had
elapsed since incidence. For these, there was 89% com-
pleteness of registration by the registries in England by the
end of the study period (Villard-Mackintosh et al., 1988),
(There was lower completeness by the study end-date for
cancers incident 1984-85, for which fewer years had yet
elapsed). A study of 50 independently identified breast
cancers, mainly from London, implied 92% eventual com-
pleteness at regional level (Hunt & Coleman, 1987). An
analysis based on the national childhood register suggests
95% completeness of registration at regional level and 92%
at national level for cancers in children 1971-84 (Hawkins &
Swerdlow, in press). Registration is likely to be easier, and
completeness greater, in children than in adults, however.
Ninety five per cent or greater completeness has been sug-
gested for certain regional registries (Nwene & Smith, 1982;
Trout, 1982; Waterhouse, 1987), but in only one instance
(Nwene & Smith, 1982) was a comparison to an independent
registration source presented. Indirect evidence from mor-
tality to registration ratios suggests considerable regional
variation in completeness (Swerdlow, 1986), but does not
enable quantification of this. The differences, however, are in
general in the same directions as the data presented here.
Thus in summary, the present data and consideration of
previous smaller studies and indirect evidence suggest that
during the period 1971-84 England and Wales cancer regis-
tration was about or slightly over 90% complete at regional
level, that about 3% of the registrations then failed to reach
the national registry, and that there was considerable
regional variation in completeness, with figures in several
regions of 95% or better.
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